EMA: Final Guideline on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD)

This guideline is a revision of the CPMP Points to Consider on Clinical Investigation of Medicinal Products in the Chronic Treatment of Patients with Chronic Obstructive Pulmonary Disease (COPD) (CPMP/EWP562/98). It is intended to update this previous guidance with new scientific knowledge of the disease as stated in new and updated clinical guidelines and to revise the requirements for the clinical investigation of medicinal products for the treatment of COPD accordingly.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny